Wordt geladen...
HCC—subtypes, stratification and sorafenib
The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspectiv...
Bewaard in:
| Gepubliceerd in: | Nat Rev Gastroenterol Hepatol |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5526453/ https://ncbi.nlm.nih.gov/pubmed/25245016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrgastro.2014.157 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|